Murphy Keith 4
4 · Kintara Therapeutics, Inc. · Filed Aug 21, 2020
Insider Transaction Report
Form 4
Murphy Keith
Director
Transactions
- Purchase
Common Stock
2020-08-19+181,010→ 181,010 total
Footnotes (1)
- [F1]Received in exchange for 115,000 shares of Adgero Biopharmaceuticals Holdings, Inc. ("Adgero") common stock, par value $0.0001 per share, in connection with the completion of the merger (the "Merger"), on August 19, 2020 (the "Effective Date"), of Adgero Acquisition Corp., a subsidiary of the Issuer, with and into Adgero, pursuant to the Agreement and Plan of Merger and Reorganization, dated as of June 9, 2020. On the Effective Date, each share of Adgero common stock was converted automatically into the right to receive 1.5740 shares of the Issuer's common stock, par value $0.001 per share.